Study to Evaluate Pharmacokinetics, Safety & Tolerability of 101-PGC-005 in Healthy, Adult, Human Subjects

Clinical trial NCT05619770 · UNKNOWN

Trial details

NCT number: NCT05619770
Sponsor: 101 Therapeutics
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Glucocorticoids Toxicity COVID-19 Infectious Disease Virus Diseases

Start date: 2022-10-29
Primary completion: 2022-11-03
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.